Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Serrano

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Oncologist|May 21, 2021
Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and MechanismsMiguel Esperança-Martins, Lisa Gonçalves, Inês Soares-Pinho, et al.
BJUI Compass|February 19, 2024
Effectiveness of the T-Control catheter: A study protocolYolanda Ramallo-Fariña, Ana Toledo Chávarri, Adrián Amador Robayna, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2019
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markersMarta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
European Journal of Immunology|October 21, 2020
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onsetPatrícia Figueiredo-Campos, Birte Blankenhaus, Catarina Mota, et al.
Plos One|September 9, 2025
ICTUSCOG: Poststroke cognitive impairment following nondisabling stroke: Study protocol of a spanish multicentre prospective cohort studyCristina Moreno-Loscertales, Paula Canasto-Jiménez, Mario Bautista-Lacambra, et al.
European Journal of Immunology|October 25, 2021
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infectionLuísa Canto E Castro, Andreia Gomes, Marta Serrano, et al.
Emerging Infectious Diseases|August 26, 2021
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, PortugalLuísa Canto E Castro, Ana Helena Guia Pereira, Rita Ribeiro, et al.
Frontiers in Microbiology|October 28, 2021
<i>In vitro</i> Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease MicrobiomeAleix Lluansí, Marc Llirós, Lia Oliver, et al.
Frontiers in Medicine|June 30, 2022
Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal-A Multicenter, Nationwide StudyAna Rita Cruz-Machado, Sofia C Barreira, Matilde Bandeira, et al.
Anaesthesia, Critical Care & Pain Medicine|April 27, 2022
Ventilator-associated events in children: A multicentre prospective cohort studyYolanda Peña-López, Magda Campins-Martí, Maria Slöcker-Barrio, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Oncologist|May 21, 2021
Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and MechanismsMiguel Esperança-Martins, Lisa Gonçalves, Inês Soares-Pinho, et al.
BJUI Compass|February 19, 2024
Effectiveness of the T-Control catheter: A study protocolYolanda Ramallo-Fariña, Ana Toledo Chávarri, Adrián Amador Robayna, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2019
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markersMarta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
European Journal of Immunology|October 21, 2020
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onsetPatrícia Figueiredo-Campos, Birte Blankenhaus, Catarina Mota, et al.
Plos One|September 9, 2025
ICTUSCOG: Poststroke cognitive impairment following nondisabling stroke: Study protocol of a spanish multicentre prospective cohort studyCristina Moreno-Loscertales, Paula Canasto-Jiménez, Mario Bautista-Lacambra, et al.
European Journal of Immunology|October 25, 2021
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infectionLuísa Canto E Castro, Andreia Gomes, Marta Serrano, et al.
Emerging Infectious Diseases|August 26, 2021
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, PortugalLuísa Canto E Castro, Ana Helena Guia Pereira, Rita Ribeiro, et al.
Frontiers in Microbiology|October 28, 2021
<i>In vitro</i> Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease MicrobiomeAleix Lluansí, Marc Llirós, Lia Oliver, et al.
Frontiers in Medicine|June 30, 2022
Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal-A Multicenter, Nationwide StudyAna Rita Cruz-Machado, Sofia C Barreira, Matilde Bandeira, et al.
Anaesthesia, Critical Care & Pain Medicine|April 27, 2022
Ventilator-associated events in children: A multicentre prospective cohort studyYolanda Peña-López, Magda Campins-Martí, Maria Slöcker-Barrio, et al.
Pageof 7